Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema ...

TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing ...

Discover key factors shaping the 2026 stock market outlook amid Fed policy shifts and political uncertainty. Click for my ...

Commercial Metals' diversification and strategic acquisitions boost margins and growth amid strong rebar markets. Click here ...

Firefly Aerospace stock has plunged since its IPO despite lunar success and NASA contracts. Is FLY a buy-the-dip opportunity ...

What have been the defining moments of 2025 for the North West commercial property world - and what is on the horizon? Insider speaks to property experts to find out.

Here's a brief rundown of 12 of 2025's most memorable mishaps. One caveat first, though: There is no shame in being on the ...

"The success of BAM-1 Alpha is reshaping our production capabilities," said Kim Thompson, Founder and CEO of Kraig Labs. "These results reaffirm the power of this hybrid line, and to surpass the ...

Alpha Tau Medical Ltd ( ($DRTS) ) has provided an announcement. On December 18, 2025, Alpha Tau Medical Ltd. announced that CEO Uzi Sofer and CFO ...

Compact discs are seeing a modest resurgence as younger listeners rediscover physical music formats, even as long-term sales ...

Agios Pharma’s oral PK activator, Aqvesme receives US FDA approval to treat anaemia in adults with alpha- or beta-thalassemia: Cambridge, Massachusetts Friday, December 26, 2025 ...

A class action lawsuit was filed against Firefly Aerospace ($FLY) on November 11, 2025. The federal securities class action ...